CUSIP: 72942A107
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,948,954
-
Share change
-
-782,551
-
Total reported value
-
$19,311,883
-
Put/Call ratio
-
46%
-
Price per share
-
$2.43
-
Number of holders
-
44
-
Value change
-
-$2,137,778
-
Number of buys
-
11
-
Number of sells
-
22
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2022
-
Previous quarter:
Q1 2022
Recent filing periods for CUSIP 72942A107:
Institutional Holders of PLX PHARMA INC - COM (PLXPQ) as of Q2 2022
As of 30 Jun 2022,
PLX PHARMA INC - COM (PLXPQ) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,948,954 shares.
The largest 10 holders included
MSD Partners, L.P., Park West Asset Management LLC, VANGUARD GROUP INC, MORGAN STANLEY, GW&K Investment Management, LLC, BlackRock Inc., TWO SIGMA ADVISERS, LP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, and Federation des caisses Desjardins du Quebec.
This page lists
44
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.